Additionally, the expression of PD-L1 on tumor cells is related to the exhaustion of T cells, therefore blocking this pathway has been demonstrated to be a successful approach for the treatment of different types of cancers, including non-small cell lung cancer, melanoma, breast, renal cell carcinoma, and CRC (87–92). Here, CD274 is linked to colorectal carcinoma.